Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,703 | -26,512 | -17,274 | -11,328 | -7,890 |
| Depreciation Amortization | -135 | 308 | 341 | 184 | 144 |
| Accounts receivable | 1,432 | -1,436 | -20 | 694 | -94 |
| Accounts payable and accrued liabilities | -335 | -101 | N/A | N/A | N/A |
| Other Working Capital | 1,939 | -4,466 | 1,538 | 1,099 | 282 |
| Other Operating Activity | 2,958 | 4,040 | 660 | 2,453 | 5,345 |
| Operating Cash Flow | $-26,844 | $-28,167 | $-14,755 | $-6,898 | $-2,213 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,462 | N/A | 0 | N/A | N/A |
| PPE Investments | -445 | -246 | -250 | -123 | -266 |
| Net Acquisitions | N/A | 1,280 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 28 | -8 |
| Investing Cash Flow | $-29,907 | $1,034 | $-250 | $-95 | $-274 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 10,000 | N/A | N/A | 795 |
| Common Stock Issued | 44,953 | 48,982 | 213 | 13,095 | 6,644 |
| Common Stock Repurchased | N/A | -330 | N/A | -363 | N/A |
| Other Financing Activity | -3,037 | -6,182 | 15,661 | -26 | -42 |
| Financing Cash Flow | $41,916 | $52,470 | $15,874 | $12,706 | $7,397 |
| Beginning Cash Position | 47,441 | 22,104 | 21,235 | 5,119 | 209 |
| End Cash Position | 32,606 | 47,441 | 22,104 | 10,832 | 5,119 |
| Net Cash Flow | $-14,835 | $25,337 | $869 | $5,713 | $4,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,844 | -28,167 | -14,755 | -6,898 | -2,213 |
| Capital Expenditure | -445 | -246 | -250 | -123 | -266 |
| Free Cash Flow | -27,289 | -28,413 | -15,005 | -7,021 | -2,479 |